Skip to main content

Circular · DGFT

PUBLIC NOTICE NO. 46/2024, DT. 06/02/2025

Dated
06 Feb 2025
Reference no.
46/2024-25

Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.

(TO BE PUBLISHED IN THE GAZETTE OF INDIA EXTRAORDINARY (PART-1

(SECTION-1)

Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Public Notice No.46 /2024-25

New Delhi, Dated February, 2025

Subject: Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.

In exercise of the powers conferred under paragraphs 1.03 and 2.04 of the Foreign Trade Policy-2023 as amended from time to time, the Director General of Foreign Trade makes the following amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.

SI. No.Import Item/sz Quantity 4
IErythromycin Stearate334 mg.

Note: For other variants of export items, norms may be worked out on a pro-rata basis.

Effect of the Public Notice: Standard Input Output Norm appearing under A-222 is amended as above with immediate effect.

Ww
;

a
(Santosh Sarangi)

Director General of Foreign Trade
Ex-officio Addl. Secretary to the Government of India e-mail: dgft@nic.in
(issued from File No.

Source: Directorate General of Foreign Trade (DGFT). View the official PDF.